• Discussion on the POINT trial (with Marc Fisher and Greg Albers)

  • Mar 2 2021
  • Duración: 18 m
  • Podcast

Discussion on the POINT trial (with Marc Fisher and Greg Albers)  Por  arte de portada

Discussion on the POINT trial (with Marc Fisher and Greg Albers)

  • Resumen

  • Professor Marc Fisher and Dr Greg Albers discuss the POINT trial, also commenting on when to consider ticagrelor versus clopidogrel.

    This programme is made possible thanks to an independent educational grant from AstraZeneca.

    Find more information at https://ime.springerhealthcare.com/programs/emerging-dual-anti-platelet-therapy-strategies-for-neurologists-in-secondary-stroke-prevention/

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Discussion on the POINT trial (with Marc Fisher and Greg Albers)

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.